{"transactions":[{"id":1429778,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning and Communications"}}],"security":"Common Stock","published_at":"2024-08-19T20:11:23.000Z","date":"2024-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":731,"price":1.5,"value":1096.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 2/15/2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"Share numbers reflect the 1:24 reverse stock split effected on 5/2/2024."}],"balance_after":5867,"source":{"system":"sec-edgar","filing":"0001104659-24-090983","document":"tm2422096-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000110465924090983/tm2422096-3_4seq1.xml","form_type":"4"}},{"id":1638847,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Planning and Corporate Com"}}],"security":"Common Stock","published_at":"2024-02-16T18:25:26.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0.3,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/15/2024 and the remaining 50% on 2/15/2025."}],"balance_after":108326,"source":{"system":"sec-edgar","filing":"0001104659-24-025032","document":"tm246574-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000110465924025032/tm246574-3_4seq1.xml","form_type":"4"}},{"id":2017154,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning and Communications"}}],"security":"Common Stock","published_at":"2023-02-14T15:56:24.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":1029,"price":3.59,"value":3694.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 2/10/2022"}],"balance_after":8323,"source":{"system":"sec-edgar","filing":"0001628280-23-003495","document":"wf-form4_167640816918910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000162828023003495/wf-form4_167640816918910.xml","form_type":"4"}},{"id":2054950,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning and Communications"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-13T16:28:46.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest and become exercisable in equal quarterly installments over 4 years from 1/12/2023, beginning on 4/12/2023 and ending on 1/12/2027."}],"balance_after":18000,"derivative":{"exercise_price":3.15,"expiration_date":"2033-01-12","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001628280-23-001036","document":"wf-form4_167364530810770.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000162828023001036/wf-form4_167364530810770.xml","form_type":"4"}},{"id":2187216,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning and Comms"}}],"security":"Common Stock","published_at":"2022-08-12T11:32:15.000Z","date":"2022-08-10","kind":"tax_withholding","acquired":false,"shares":864,"price":2.68,"value":2315.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 2/10/2022."}],"balance_after":9352,"source":{"system":"sec-edgar","filing":"0001104659-22-089863","document":"tm2223300-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000110465922089863/tm2223300-3_4seq1.xml","form_type":"4"}},{"id":2355788,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning and Comms"}}],"security":"Common Stock","published_at":"2022-03-03T19:53:53.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":366,"price":4.25,"value":1555.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 3/1/2021."}],"balance_after":10216,"source":{"system":"sec-edgar","filing":"0001104659-22-030200","document":"tm228387-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000110465922030200/tm228387-2_4seq1.xml","form_type":"4"}},{"id":2398731,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning and Comms"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-14T14:33:07.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options will vest and become exercisable in equal quarterly installments over 4 years from 2/10/2022, beginning on 5/10/2022 and ending on 2/10/2026."}],"balance_after":18000,"derivative":{"exercise_price":3.83,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001179110-22-001143","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911022001143/edgar.xml","form_type":"4"}},{"id":2398730,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning and Comms"}}],"security":"Common Stock","published_at":"2022-02-14T14:33:07.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":5891,"price":3.83,"value":22562.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/10/2022 and the remaining 50% on 2/10/2023."}],"balance_after":10582,"source":{"system":"sec-edgar","filing":"0001179110-22-001143","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911022001143/edgar.xml","form_type":"4"}},{"id":2556893,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning and Comms"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-29T19:52:07.000Z","date":"2021-09-28","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest and become exercisable in equal quarterly installments over 4 years from 9/28/2021, beginning on 12/28/2021 and ending on 9/28/2025."}],"balance_after":18000,"derivative":{"exercise_price":6.3,"expiration_date":"2031-09-28","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001179110-21-009009","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911021009009/edgar.xml","form_type":"4"}},{"id":2579899,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning and Comms"}}],"security":"Common Stock","published_at":"2021-09-03T17:17:27.000Z","date":"2021-09-01","kind":"tax_withholding","acquired":false,"shares":307,"price":6.71,"value":2059.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 3/1/2021."}],"balance_after":4691,"source":{"system":"sec-edgar","filing":"0001179110-21-008614","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911021008614/edgar.xml","form_type":"4"}},{"id":2814953,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning & Comms"}}],"security":"Common Stock","published_at":"2021-03-03T13:54:20.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":2092,"price":16.03,"value":33534.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 09/01/2021 and the remaining 50% on 03/01/2022."}],"balance_after":4998,"source":{"system":"sec-edgar","filing":"0001179110-21-002637","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911021002637/edgar.xml","form_type":"4"}},{"id":2859871,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning & Comms"}}],"security":"Common Stock","published_at":"2021-02-16T11:13:40.000Z","date":"2021-02-11","kind":"tax_withholding","acquired":false,"shares":693,"price":22.77,"value":15779.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld in payment of withholding taxes upon vesting of RSUs granted 2/11/20."}],"balance_after":2906,"source":{"system":"sec-edgar","filing":"0001179110-21-001668","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911021001668/edgar.xml","form_type":"4"}},{"id":2893670,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning & Comms"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-27T10:40:42.000Z","date":"2021-01-25","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest and become exercisable in equal quarterly installments over 4 years from 1/25/2021, beginning on 4/25/2021 and ending on 1/25/2025."}],"balance_after":11500,"derivative":{"exercise_price":16.49,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001179110-21-000864","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911021000864/edgar.xml","form_type":"4"}},{"id":3058927,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning & Comms"}}],"security":"Common Stock","published_at":"2020-08-13T18:00:30.000Z","date":"2020-08-11","kind":"tax_withholding","acquired":false,"shares":587,"price":6.55,"value":3844.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld in payment of withholding taxes upon vesting of RSUs granted 2/11/20."}],"balance_after":3599,"source":{"system":"sec-edgar","filing":"0001179110-20-009011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911020009011/edgar.xml","form_type":"4"}},{"id":3131018,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning & Comms"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-29T15:54:59.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest and become exercisable in equal quarterly installments over 4 years from 5/28/2020, beginning on 8/28/2020 and ending on 5/28/2024."}],"balance_after":21000,"derivative":{"exercise_price":5.86,"expiration_date":"2030-05-28","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001179110-20-006704","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911020006704/edgar.xml","form_type":"4"}},{"id":3274639,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning & Comms"}}],"security":"Common Stock","published_at":"2020-02-13T16:10:27.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/11/20 and the remaining 50% on 2/11/21."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"All share numbers reported reflect the 1-for-40 reverse stock split effected on January 15, 2020."}],"balance_after":4186,"source":{"system":"sec-edgar","filing":"0001179110-20-001559","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911020001559/edgar.xml","form_type":"4"}},{"id":3513712,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning & Comms"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-23T16:28:26.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest and become exercisable in equal quarterly installments over 4 years from 5/22/19, beginning on 8/22/2019 and ending on 5/22/2023."}],"balance_after":60000,"derivative":{"exercise_price":0.9,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001179110-19-006574","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911019006574/edgar.xml","form_type":"4"}},{"id":3565806,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning & Comms"}}],"security":"Common Stock","published_at":"2019-04-03T19:38:52.000Z","date":"2019-04-01","kind":"tax_withholding","acquired":false,"shares":679,"price":1.16,"value":787.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld in payment of withholding taxes upon vesting of RSUs granted 4/1/15."}],"balance_after":7469,"source":{"system":"sec-edgar","filing":"0001179110-19-004747","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911019004747/edgar.xml","form_type":"4"}},{"id":3565805,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning & Comms"}}],"security":"Common Stock","published_at":"2019-04-03T19:38:12.000Z","date":"2018-04-01","kind":"tax_withholding","acquired":false,"shares":739,"price":1.95,"value":1441.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld in payment of withholding taxes upon vesting of RSUs granted 4/1/15."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,958 restricted stock units."}],"balance_after":8208,"source":{"system":"sec-edgar","filing":"0001179110-19-004746","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911019004746/edgar.xml","form_type":"5"}},{"id":3917355,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning & Comms"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-25T10:57:47.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest and become exercisable in equal quarterly installments over 4 years from 5/23/18, beginning on 8/23/2018 and ending on 5/23/2022."}],"balance_after":100000,"derivative":{"exercise_price":1.65,"expiration_date":"2028-05-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-18-007514","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911018007514/edgar.xml","form_type":"4"}},{"id":4361958,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning & Comms"}}],"security":"Common Stock","published_at":"2017-04-04T18:34:35.000Z","date":"2017-04-01","kind":"tax_withholding","acquired":false,"shares":7392,"price":0.37,"value":2735.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld in payment of withholding taxes upon vesting of RSUs granted 4/1/15."}],"balance_after":89474,"source":{"system":"sec-edgar","filing":"0001179110-17-005671","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911017005671/edgar.xml","form_type":"4"}},{"id":4573026,"issuer":{"id":88195,"kind":"organization","name":"YIELD10 BIOSCIENCE, INC.","symbol":"YTEN"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Planning & Comms"}}],"security":"Stock Option (right to buy)","published_at":"2016-10-28T16:02:53.000Z","date":"2016-10-26","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest and become exercisable in 4 equal semi-annual installments over 2 years from 10/26/16."}],"balance_after":500000,"derivative":{"exercise_price":0.53,"expiration_date":"2026-10-26","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001179110-16-030981","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121702/000117911016030981/edgar.xml","form_type":"4"}},{"id":608742,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-05-09T20:40:21.000Z","date":"2006-05-08","kind":"grant","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/97."}],"balance_after":277933,"derivative":{"exercise_price":13.67,"exercise_date":"1998-03-12","expiration_date":"2007-12-11","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0000875320-06-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000042/edgar.xml","form_type":"4"}},{"id":608741,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-05-09T20:40:21.000Z","date":"2006-05-08","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":279183,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000042/edgar.xml","form_type":"4"}},{"id":608740,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-05-09T20:40:21.000Z","date":"2006-05-08","kind":"sale","acquired":false,"shares":1250,"price":36.57,"value":45712.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":46199,"source":{"system":"sec-edgar","filing":"0000875320-06-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000042/edgar.xml","form_type":"4"}},{"id":608739,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-05-09T20:40:21.000Z","date":"2006-05-08","kind":"exercise","acquired":true,"shares":1250,"price":13.67,"value":17087.5,"ownership":{"direct":true},"balance_after":47449,"source":{"system":"sec-edgar","filing":"0000875320-06-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000042/edgar.xml","form_type":"4"}},{"id":608738,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-05-09T20:40:21.000Z","date":"2006-05-08","kind":"sale","acquired":false,"shares":1000,"price":36.57,"value":36570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":46199,"source":{"system":"sec-edgar","filing":"0000875320-06-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000042/edgar.xml","form_type":"4"}},{"id":608737,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-05-09T20:40:21.000Z","date":"2006-05-08","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":47199,"source":{"system":"sec-edgar","filing":"0000875320-06-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000042/edgar.xml","form_type":"4"}},{"id":609697,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-05-02T17:39:32.000Z","date":"2006-05-01","kind":"grant","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/97."}],"balance_after":280183,"derivative":{"exercise_price":13.67,"exercise_date":"1998-03-12","expiration_date":"2007-12-11","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0000875320-06-000040","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000040/edgar.xml","form_type":"4"}},{"id":609696,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-05-02T17:39:32.000Z","date":"2006-05-01","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":281433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000040","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000040/edgar.xml","form_type":"4"}},{"id":609695,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-05-02T17:39:32.000Z","date":"2006-05-01","kind":"sale","acquired":false,"shares":1250,"price":35.77,"value":44712.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":46199,"source":{"system":"sec-edgar","filing":"0000875320-06-000040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000040/edgar.xml","form_type":"4"}},{"id":609694,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-05-02T17:39:32.000Z","date":"2006-05-01","kind":"exercise","acquired":true,"shares":1250,"price":13.67,"value":17087.5,"ownership":{"direct":true},"balance_after":47449,"source":{"system":"sec-edgar","filing":"0000875320-06-000040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000040/edgar.xml","form_type":"4"}},{"id":609693,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-05-02T17:39:32.000Z","date":"2006-05-01","kind":"sale","acquired":false,"shares":1000,"price":35.77,"value":35770.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":46199,"source":{"system":"sec-edgar","filing":"0000875320-06-000040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000040/edgar.xml","form_type":"4"}},{"id":609692,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-05-02T17:39:32.000Z","date":"2006-05-01","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":47199,"source":{"system":"sec-edgar","filing":"0000875320-06-000040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000040/edgar.xml","form_type":"4"}},{"id":610565,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-04-25T17:41:11.000Z","date":"2006-04-24","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":282433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000039","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000039/edgar.xml","form_type":"4"}},{"id":610564,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-04-25T17:41:11.000Z","date":"2006-04-24","kind":"sale","acquired":false,"shares":1000,"price":38.33,"value":38330.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":46199,"source":{"system":"sec-edgar","filing":"0000875320-06-000039","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000039/edgar.xml","form_type":"4"}},{"id":610563,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-04-25T17:41:11.000Z","date":"2006-04-24","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":47199,"source":{"system":"sec-edgar","filing":"0000875320-06-000039","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000039/edgar.xml","form_type":"4"}},{"id":611368,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-04-18T18:06:21.000Z","date":"2006-04-17","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":283433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000037","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000037/edgar.xml","form_type":"4"}},{"id":611367,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-04-18T18:06:21.000Z","date":"2006-04-17","kind":"sale","acquired":false,"shares":1000,"price":35.79,"value":35790.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":46199,"source":{"system":"sec-edgar","filing":"0000875320-06-000037","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000037/edgar.xml","form_type":"4"}},{"id":611366,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-04-18T18:06:21.000Z","date":"2006-04-17","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":47199,"source":{"system":"sec-edgar","filing":"0000875320-06-000037","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000037/edgar.xml","form_type":"4"}},{"id":611775,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-04-11T17:35:14.000Z","date":"2006-04-10","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":284433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000036","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000036/edgar.xml","form_type":"4"}},{"id":611774,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-04-11T17:35:14.000Z","date":"2006-04-10","kind":"sale","acquired":false,"shares":1000,"price":33.92,"value":33920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":46199,"source":{"system":"sec-edgar","filing":"0000875320-06-000036","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000036/edgar.xml","form_type":"4"}},{"id":611773,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-04-11T17:35:14.000Z","date":"2006-04-10","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":47199,"source":{"system":"sec-edgar","filing":"0000875320-06-000036","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000036/edgar.xml","form_type":"4"}},{"id":612472,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-04-04T15:16:01.000Z","date":"2006-04-03","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":285433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000034","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000034/edgar.xml","form_type":"4"}},{"id":612471,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-04-04T15:16:01.000Z","date":"2006-04-03","kind":"sale","acquired":false,"shares":1000,"price":35.98,"value":35980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":46199,"source":{"system":"sec-edgar","filing":"0000875320-06-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000034/edgar.xml","form_type":"4"}},{"id":612470,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-04-04T15:16:01.000Z","date":"2006-04-03","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":47199,"source":{"system":"sec-edgar","filing":"0000875320-06-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000034/edgar.xml","form_type":"4"}},{"id":613063,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-03-28T21:16:08.000Z","date":"2006-03-27","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":286433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000033","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000033/edgar.xml","form_type":"4"}},{"id":613062,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-03-28T21:16:08.000Z","date":"2006-03-20","kind":"sale","acquired":false,"shares":1000,"price":35.87,"value":35870.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":46199,"source":{"system":"sec-edgar","filing":"0000875320-06-000033","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000033/edgar.xml","form_type":"4"}},{"id":613061,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-03-28T21:16:08.000Z","date":"2006-03-27","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":47199,"source":{"system":"sec-edgar","filing":"0000875320-06-000033","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000033/edgar.xml","form_type":"4"}},{"id":613159,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-03-27T16:57:30.000Z","date":"2006-03-24","kind":"sale","acquired":false,"shares":1988,"price":36.56,"value":72681.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":46199,"source":{"system":"sec-edgar","filing":"0000875320-06-000031","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000031/edgar.xml","form_type":"4"}},{"id":613595,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-03-21T17:38:44.000Z","date":"2006-03-20","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":287433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000029","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000029/edgar.xml","form_type":"4"}},{"id":613594,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-03-21T17:38:44.000Z","date":"2006-03-20","kind":"sale","acquired":false,"shares":400,"price":40.12,"value":16048.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":48187,"source":{"system":"sec-edgar","filing":"0000875320-06-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000029/edgar.xml","form_type":"4"}},{"id":613593,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-03-21T17:38:44.000Z","date":"2006-03-20","kind":"sale","acquired":false,"shares":1000,"price":40.12,"value":40120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":48587,"source":{"system":"sec-edgar","filing":"0000875320-06-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000029/edgar.xml","form_type":"4"}},{"id":613592,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-03-21T17:38:44.000Z","date":"2006-03-20","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":49587,"source":{"system":"sec-edgar","filing":"0000875320-06-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000029/edgar.xml","form_type":"4"}},{"id":614644,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-03-14T17:32:26.000Z","date":"2006-03-13","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":288433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000026","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000026/edgar.xml","form_type":"4"}},{"id":614643,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-03-14T17:32:26.000Z","date":"2006-03-13","kind":"sale","acquired":false,"shares":1000,"price":37.23,"value":37230.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":48587,"source":{"system":"sec-edgar","filing":"0000875320-06-000026","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000026/edgar.xml","form_type":"4"}},{"id":614642,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-03-14T17:32:26.000Z","date":"2006-03-13","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":49587,"source":{"system":"sec-edgar","filing":"0000875320-06-000026","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000026/edgar.xml","form_type":"4"}},{"id":615441,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-03-07T18:31:48.000Z","date":"2006-03-06","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":289433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000025","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000025/edgar.xml","form_type":"4"}},{"id":615440,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-03-07T18:31:48.000Z","date":"2006-03-06","kind":"sale","acquired":false,"shares":1000,"price":43.94,"value":43940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":48587,"source":{"system":"sec-edgar","filing":"0000875320-06-000025","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000025/edgar.xml","form_type":"4"}},{"id":615439,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-03-07T18:31:48.000Z","date":"2006-03-06","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":49587,"source":{"system":"sec-edgar","filing":"0000875320-06-000025","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000025/edgar.xml","form_type":"4"}},{"id":616436,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-02-28T19:06:00.000Z","date":"2006-02-27","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":290433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000023","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000023/edgar.xml","form_type":"4"}},{"id":616435,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-02-28T19:06:00.000Z","date":"2006-02-27","kind":"sale","acquired":false,"shares":1000,"price":43.87,"value":43870.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":48587,"source":{"system":"sec-edgar","filing":"0000875320-06-000023","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000023/edgar.xml","form_type":"4"}},{"id":616434,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-02-28T19:06:00.000Z","date":"2006-02-27","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":49587,"source":{"system":"sec-edgar","filing":"0000875320-06-000023","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000023/edgar.xml","form_type":"4"}},{"id":617070,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-02-22T18:54:17.000Z","date":"2006-02-21","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":291433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000021","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000021/edgar.xml","form_type":"4"}},{"id":617069,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-02-22T18:54:17.000Z","date":"2006-02-21","kind":"sale","acquired":false,"shares":1000,"price":37.13,"value":37130.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":48587,"source":{"system":"sec-edgar","filing":"0000875320-06-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000021/edgar.xml","form_type":"4"}},{"id":617068,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-02-22T18:54:17.000Z","date":"2006-02-21","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":49587,"source":{"system":"sec-edgar","filing":"0000875320-06-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000021/edgar.xml","form_type":"4"}},{"id":618435,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-02-14T17:42:16.000Z","date":"2006-02-13","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":292433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000018","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000018/edgar.xml","form_type":"4"}},{"id":618434,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-02-14T17:42:16.000Z","date":"2006-02-13","kind":"sale","acquired":false,"shares":1000,"price":34.96,"value":34960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":48587,"source":{"system":"sec-edgar","filing":"0000875320-06-000018","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000018/edgar.xml","form_type":"4"}},{"id":618433,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-02-14T17:42:16.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":49587,"source":{"system":"sec-edgar","filing":"0000875320-06-000018","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000018/edgar.xml","form_type":"4"}},{"id":619650,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-02-07T20:02:09.000Z","date":"2006-02-06","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":293433,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000017","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000017/edgar.xml","form_type":"4"}},{"id":619649,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-02-07T20:02:09.000Z","date":"2006-02-06","kind":"sale","acquired":false,"shares":1000,"price":34.33,"value":34330.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":48587,"source":{"system":"sec-edgar","filing":"0000875320-06-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000017/edgar.xml","form_type":"4"}},{"id":619648,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-02-07T20:02:09.000Z","date":"2006-02-06","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":49587,"source":{"system":"sec-edgar","filing":"0000875320-06-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000017/edgar.xml","form_type":"4"}},{"id":619816,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-02-06T21:45:36.000Z","date":"2006-02-02","kind":"grant","acquired":true,"shares":14066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/02/2006."}],"balance_after":294433,"derivative":{"exercise_price":35.64,"exercise_date":"2006-05-02","expiration_date":"2016-02-01","underlying":"Common stock","underlying_shares":14066},"source":{"system":"sec-edgar","filing":"0000875320-06-000014","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000014/edgar.xml","form_type":"4"}},{"id":619815,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-02-06T21:45:36.000Z","date":"2006-02-02","kind":"grant","acquired":true,"shares":3240,"price":0.01,"value":32.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 1996 Stock and Option Plan, vesting on 2/2/2010, subject to acceleration upon achievement of certain performance-based milestones."}],"balance_after":48587,"source":{"system":"sec-edgar","filing":"0000875320-06-000014","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000014/edgar.xml","form_type":"4"}},{"id":620929,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-02-01T17:54:07.000Z","date":"2006-01-31","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":280367,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000006","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000006/edgar.xml","form_type":"4"}},{"id":620928,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-02-01T17:54:07.000Z","date":"2006-01-31","kind":"sale","acquired":false,"shares":1000,"price":35.29,"value":35290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":44196,"source":{"system":"sec-edgar","filing":"0000875320-06-000006","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000006/edgar.xml","form_type":"4"}},{"id":620927,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-02-01T17:54:07.000Z","date":"2006-01-31","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":45196,"source":{"system":"sec-edgar","filing":"0000875320-06-000006","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000006/edgar.xml","form_type":"4"}},{"id":621972,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Stock Option","published_at":"2006-01-24T20:31:38.000Z","date":"2006-01-23","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1995 Stock and Option Plan, vesting quarterly over 5 years from 12/14/95."}],"balance_after":281367,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000003","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000003/edgar.xml","form_type":"4"}},{"id":621971,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-01-24T20:31:38.000Z","date":"2006-01-23","kind":"sale","acquired":false,"shares":1000,"price":33.63,"value":33630.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":44196,"source":{"system":"sec-edgar","filing":"0000875320-06-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000003/edgar.xml","form_type":"4"}},{"id":621970,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Strategic Communications"}}],"security":"Common Stock","published_at":"2006-01-24T20:31:38.000Z","date":"2006-01-23","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":45196,"source":{"system":"sec-edgar","filing":"0000875320-06-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000003/edgar.xml","form_type":"4"}},{"id":622438,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Stock Option","published_at":"2006-01-18T17:13:02.000Z","date":"2006-01-17","kind":"grant","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96."}],"balance_after":282367,"derivative":{"exercise_price":15.56,"exercise_date":"1997-03-12","expiration_date":"2006-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-06-000002","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000002/edgar.xml","form_type":"4"}},{"id":622437,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Common Stock","published_at":"2006-01-18T17:13:02.000Z","date":"2006-01-17","kind":"sale","acquired":false,"shares":1000,"price":33.62,"value":33620.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":44196,"source":{"system":"sec-edgar","filing":"0000875320-06-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000002/edgar.xml","form_type":"4"}},{"id":622436,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Common Stock","published_at":"2006-01-18T17:13:02.000Z","date":"2006-01-17","kind":"exercise","acquired":true,"shares":1000,"price":15.56,"value":15560.0,"ownership":{"direct":true},"balance_after":45196,"source":{"system":"sec-edgar","filing":"0000875320-06-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000002/edgar.xml","form_type":"4"}},{"id":626271,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Stock Option","published_at":"2005-12-07T20:19:11.000Z","date":"2005-12-06","kind":"grant","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1995 Stock and Option Plan, vesting quarterly over 5 years from 12/14/95."}],"balance_after":283367,"derivative":{"exercise_price":9.5,"exercise_date":"1996-03-14","expiration_date":"2005-12-13","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000875320-05-000071","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532005000071/edgar.xml","form_type":"4"}},{"id":626270,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Common Stock","published_at":"2005-12-07T20:19:11.000Z","date":"2005-12-06","kind":"sale","acquired":false,"shares":2000,"price":24.8,"value":49600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1."}],"balance_after":44196,"source":{"system":"sec-edgar","filing":"0000875320-05-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532005000071/edgar.xml","form_type":"4"}},{"id":626269,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Common Stock","published_at":"2005-12-07T20:19:11.000Z","date":"2005-12-06","kind":"exercise","acquired":true,"shares":2000,"price":9.5,"value":19000.0,"ownership":{"direct":true},"balance_after":46196,"source":{"system":"sec-edgar","filing":"0000875320-05-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532005000071/edgar.xml","form_type":"4"}},{"id":635916,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Stock Option","published_at":"2005-07-22T19:04:13.000Z","date":"2005-07-20","kind":"grant","acquired":true,"shares":10230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/20/2005."}],"balance_after":285367,"derivative":{"exercise_price":17.16,"exercise_date":"2005-10-20","expiration_date":"2015-07-19","underlying":"Common stock","underlying_shares":10230},"source":{"system":"sec-edgar","filing":"0000875320-05-000043","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532005000043/edgar.xml","form_type":"4"}},{"id":646398,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Stock Option","published_at":"2005-02-07T21:33:45.000Z","date":"2005-02-03","kind":"grant","acquired":true,"shares":10313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/03/2005."}],"balance_after":275137,"derivative":{"exercise_price":10.41,"exercise_date":"2005-05-03","expiration_date":"2015-02-02","underlying":"Common stock","underlying_shares":10313},"source":{"system":"sec-edgar","filing":"0000875320-05-000007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532005000007/edgar.xml","form_type":"4"}},{"id":646397,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Common Stock","published_at":"2005-02-07T21:33:45.000Z","date":"2005-02-03","kind":"grant","acquired":true,"shares":2375,"price":0.01,"value":23.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 1996 Stock and Option Plan, vesting on 2/3/2009, subject to acceleration upon achievement of certain performance-based milestones."}],"balance_after":44196,"source":{"system":"sec-edgar","filing":"0000875320-05-000007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532005000007/edgar.xml","form_type":"4"}},{"id":652667,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Stock Option","published_at":"2004-10-12T18:37:09.000Z","date":"2004-10-07","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years."}],"balance_after":264824,"derivative":{"exercise_price":11.27,"exercise_date":"2005-01-07","expiration_date":"2014-10-06","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000875320-04-000105","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532004000105/edgar.xml","form_type":"4"}},{"id":656978,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Common Stock","published_at":"2004-05-10T19:59:55.000Z","date":"2004-05-06","kind":"grant","acquired":true,"shares":35000,"price":0.01,"value":350.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 1996 Stock and Option Plan, vesting 50% on May 6, 2009, subject to acceleration upon achievement of a performance-based milestone based on Company profitability, and 50% on May 6, 2007."}],"balance_after":41821,"source":{"system":"sec-edgar","filing":"0000875320-04-000048","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532004000048/edgar.xml","form_type":"4"}},{"id":659032,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Stock Option","published_at":"2004-03-19T20:09:41.000Z","date":"2004-03-17","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 03/17/2004."}],"balance_after":257324,"derivative":{"exercise_price":9.69,"exercise_date":"2004-06-17","expiration_date":"2014-03-16","underlying":"Common stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000875320-04-000018","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532004000018/edgar.xml","form_type":"4"}},{"id":659031,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Common Stock","published_at":"2004-03-19T20:09:41.000Z","date":"2004-03-17","kind":"grant","acquired":true,"shares":800,"price":0.01,"value":8.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 1996 Stock and Option Plan, vesting on 3/17/2008, subject to acceleration upon achievement of certain peformance-based milestones."}],"balance_after":6821,"source":{"system":"sec-edgar","filing":"0000875320-04-000018","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532004000018/edgar.xml","form_type":"4"}},{"id":663597,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Stock Option","published_at":"2003-12-15T21:18:53.000Z","date":"2003-12-11","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003."}],"balance_after":251324,"derivative":{"exercise_price":9.07,"exercise_date":"2004-03-11","expiration_date":"2013-12-10","underlying":"Common stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000875320-03-000056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532003000056/edgar.xml","form_type":"4"}},{"id":663596,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17409,"kind":"person","name":"BRUM LYNNE H","position":1,"cik":"0001197017","reported_name":"BRUM LYNNE H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Corp. Comm.&Financial Plan"}}],"security":"Common Stock","published_at":"2003-12-15T21:18:53.000Z","date":"2003-12-11","kind":"grant","acquired":true,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003."}],"balance_after":6021,"source":{"system":"sec-edgar","filing":"0000875320-03-000056","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532003000056/edgar.xml","form_type":"4"}}]}